Genmab Overview
Genmab Target Price
Analysts' 12-month price predictions for GMAB.
Share Price
$20.74
Average Target Price
$45.00
117% upside
117% upside1 analysts in the last 4 months
High: $45 | Low: $45
Analyst Recommendations
No recommendations in the last 4 months.
Revenue & Income Forecast
Analysts' Target Prices
| Date | Analyst | Price Target | Current Upside/Downside | |
|---|---|---|---|---|
| 2025-03-11 | Truist FinancialAsthika Goonewardene | $45 | 117% upside |  |
| 2024-09-04 | Morgan StanleyVikram Purohit | $31 | 49.5% upside | |
| 2024-08-09 | BMO CapitalEtzer Darout | $46 | 121.8% upside | |
| 2024-06-27 | BTIGKaveri Pohlman | $47 | 126.6% upside | |
| 2024-06-27 | H.C. WainwrightRaghuram Selvaraju | $50 | 141.1% upside | |
| 2024-06-04 | Truist FinancialAsthika Goonewardene | $53 | 155.5% upside | |
| 2024-02-23 | BMO CapitalEtzer Darout | $48 | 131.4% upside | |
| 2023-02-06 | Leerink Partners | $36 | 73.6% upside | |
| 2022-11-28 | Morgan StanleyMatthew Harrison | $34 | 63.9% upside | |
| 2022-05-02 | Cowen & Co. | $38 | 83.2% upside | |